Substance Abuse Risk and Medication Monitoring in Patients with Advanced Lung Cancer Receiving Palliative Care
| Autor: | Maureen L. Saphire, Julia L Agne, Carolyn J Presley, Pooja S. Kumar, Jason A. Benedict, Erin M. Bertino, Madison Grogan, Sarah Janse |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Lung Neoplasms Palliative care Risk Assessment 03 medical and health sciences 0302 clinical medicine medicine Humans Pharmacology (medical) Medication monitoring In patient Prospective Studies 030212 general & internal medicine Intensive care medicine Lung cancer business.industry Palliative Care Opioid-Related Disorders medicine.disease Compliance Monitoring Analgesics Opioid Substance Abuse Detection Substance abuse Anesthesiology and Pain Medicine Risk screening Opioid 030220 oncology & carcinogenesis business medicine.drug |
| Zdroj: | Journal of Pain & Palliative Care Pharmacotherapy. 35:91-99 |
| ISSN: | 1536-0539 1536-0288 |
| Popis: | Oncology and Palliative Medicine lack guidance on routine opioid risk screening and compliance monitoring. This study explored relationships among risk screening and aberrant medication related behaviors in patients with advanced lung cancer receiving embedded palliative care. This was a single center, prospective study and data was collected from December 2018 to March 2020. At the initial palliative visit, patients provided a baseline urine drug screen (UDS) test and completed the Screener and Opioid Assessment for Patients with Pain - Revised (SOAPP-R) self-assessment. Clinical pharmacists provided comprehensive review and interpretation of UDS results. Among 39 patients, 12 (30.8%) scored positive for risk of aberrant medication behaviors on the SOAPP-R. Only 34 of 39 patients provided a baseline UDS test and were included in further analysis. Prior to pharmacist review, 11/11 (100%) baseline UDS results in the positive-risk group and 13/23 (56.5%) in the negative-risk group appeared unexpected ( |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|